By proceeding, you agree to our Terms of Use and Privacy Policy.
The 2nd Annual Targeted Radiopharmaceuticals Summit US is set to take place, highlighting the industry's progress and growth as more compounds are moving through clinical trials. This event is the only industry-led meeting dedicated to accelerating TRP programs by discovering more specific tumor-associated targets, increasing access to low-cost radionuclides, and maximizing preclinical and clinical research for combination therapy with other agents and treatment modalities.Over 100 key stakeholders from various sectors such as large pharma, biotech, academia, physicians, nuclear physicists, cyclotron providers, manufacturers, linker developers, and TRP-experienced CROs are expected to attend. The event aims to bring targeted radiotherapies to the forefront of cancer treatment.Attendees will have the opportunity to connect with all the key players in the targeted radiopharmaceuticals space and gain a deep and holistic understanding of the current state-of-play in the US TRP landscape, including the challenges faced by leading experts in the field.
Generate new leads through discoveries and breakthroughs in cancer treatment.
Discover specific tumor-associated targets, low-cost availability of radionuclides, maximize preclinical & clinical search of combination therapy and more.
Gain a deep and holistic insight into the current state of play in the US TRP landscape and the challenges the leading experts in the space are experiencing.
Take this unique opportunity to connect with all the key players in the industry to bring the targeted radiotherapies to the forefront of cancer treatment.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Invicro was founded with a mission of improving the role and function of imaging in translational drug discovery and development.
"Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc.
Eczacıbaşı-Monrol is an innovative, international supplier of radiopharmaceuticals for diagnosis and treatment in nuclear medicine.
MIM Software Inc. provides practical imaging solutions in the fields of Radiation Oncology, Radiology, Nuclear Medicine, Urology, Neuroimaging, and Cardiac Imaging.
Radiopharm Theranostics is developing a world-class platform of radiopharmaceutical and nuclear medicine products for both diagnostic and therapeutic uses.
Through empowering physicians with Standardized Molecular Imaging Software solutions, Hermes Medical Solutions delivers increased efficiency, accuracy for diagnosis and personalized treatment of patients. The result is improved quality and outcomes f
Through empowering physicians with Standardized Molecular Imaging Software solutions, Hermes Medical Solutions delivers increased efficiency, accuracy for diagnosis and personalized treatment of patients. The result is improved quality and outcomes for healthcare providers who are pursuing refined c
At Trasis our primary focus is allowing the medical community to access new radiolabelled therapeutic and diagnostic substances easier and faster. To this end, we design, manufacture, sell and support high performance synthesizers, dose preparation e
At Trasis our primary focus is allowing the medical community to access new radiolabelled therapeutic and diagnostic substances easier and faster. To this end, we design, manufacture, sell and support high performance synthesizers, dose preparation equipment, their shielding and accessories. We also
SHINE Technologies accelerates a practical, incremental four-phase pathway to clean, abundant fusion energy, starting with using fusion technology to solve today’s problems in medicine, manufacturing, energy, and beyond.
IONETIX is a leading molecular imaging diagnostics and therapeutics company focused on providing physicians and patients access to N-13 Ammonia. Used by a growing number of academic institutions, N-13 Ammonia is rapidly changing the standard of excel
IONETIX is a leading molecular imaging diagnostics and therapeutics company focused on providing physicians and patients access to N-13 Ammonia. Used by a growing number of academic institutions, N-13 Ammonia is rapidly changing the standard of excellence for myocardial perfusion in cardiac PET imag
ESC takes an innovative Design/Build approach to Cleanrooms through 3 vertically integrated pillars. Cleanrooms: Equipped with an entire team of architectural and process expertise, we develop process-specific layouts for your Critical Environment an
ESC takes an innovative Design/Build approach to Cleanrooms through 3 vertically integrated pillars. Cleanrooms: Equipped with an entire team of architectural and process expertise, we develop process-specific layouts for your Critical Environment and bring them to life using the ALUMA1 wall system.
At NorthStar Medical Radioisotopes, our mission is to provide patients global access to game-changing radiopharmaceuticals. We are a growing, commercialized nuclear medicine company focused on advancing patient care by providing diagnostic and therap
At NorthStar Medical Radioisotopes, our mission is to provide patients global access to game-changing radiopharmaceuticals. We are a growing, commercialized nuclear medicine company focused on advancing patient care by providing diagnostic and therapeutic radioisotopes, novel radiopharmaceuticals an
Transforming lives with radiopharmaceuticals by leveraging world class clinical, development, manufacturing, and supply chain expertise. Nucleus bridges the gap between innovation and clinic.
BIOEMTECH is a CRO that aims to bridge the gap between ex vivo studies and in vivo molecular imaging, by providing cost effective solutions in terms of instrumentation and services. BIOEMTECH has developed and commercialized the "eyes", the first des
BIOEMTECH is a CRO that aims to bridge the gap between ex vivo studies and in vivo molecular imaging, by providing cost effective solutions in terms of instrumentation and services. BIOEMTECH has developed and commercialized the "eyes", the first desktop cameras, suitable for whole body, real time i
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment. Since its foundation
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.